| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_850a17186ff51f03c607cf42a534a635 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
| filingDate |
2001-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e3c0642915fa547fa67770613a8453f |
| publicationDate |
2004-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6726932-B2 |
| titleOfInvention |
Fatty acid-containing composition |
| abstract |
The present invention provides a composition for enhancing the pharmacological activity of a water-soluble silicate polymer which comprises the water-soluble silicate polymer and a saturated fatty acid in pharmaceutically effective amounts for use as a medicine such as anti-allergic agent. The water soluble silicate polymers used according to the present invention may be obtained by polymerization and/or by extraction from plants, animals or fungi, or inflammatory tissue. The saturated fatty acid contained as an effective ingredient in the pharmaceutical composition of the present invention may be a straight chain or branched chain saturated fatty acid having about 8 carbon atoms to about 26 carbon atoms. The saturated fatty acid and water-soluble silicate polymer, effective ingredients of the present invention, can be formulated for various pharmaceutical compositions by combining with a suitable carrier or diluent for medical use. The composition of the present invention can suppress histamine release induced by a structural change in the cell membrane of the mast cell. It exhibits an excellent organism maintaining function such as cell protecting action and, therefore, is useful as a medicine such as an anti-allergic or anti-inflammatory agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293280-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010105605-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010285143-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9102758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8568789-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008112978-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006134646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9101596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010015119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006018874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7605123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006134139-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8563685-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9241908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005269753-B2 |
| priorityDate |
2000-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |